Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Phenotypic characterization of primary cardiac fibroblasts from patients with HFpEF

PLoS ONE(2022)10.1371/journal.pone.0262479Source: DataRank Database

Phenotypic characterization of primary cardiac fibroblasts from patients with HFpEF is a research paper published in PLoS ONE (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.92)OA: goldTopics (49)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

An O. Van Laer,Catalin F. Baicu ORCID,Lily S. Neff,Stanley Hoffman,Marc Katz ORCID

Live enrichment

PubMed:35015787 PMC:PMC8752005 OpenAlex:https://openalex.org/W4205356420

National Institutes of Health

Grant: 5R01-HL123478-01

NIGMS NIH HHS

Grant: T32 GM132055

U.S. Department of Veterans Affairs

Grant: CX001608

National Defense Science and Engineering Graduate

Grant: FA9550-21-F-0003

CSRD VA

Grant: I01 CX001608

NHLBI NIH HHS

Grant: R01 HL123478

National Institutes of Health

Grant: 5T32GM132055-05

Cellular, Biochemical and Molecular Sciences Training Program: Developing the skills and expertise needed for a changing biomedical landscape

National Institutes of Health

Grant: 5R01HL123478-02

Extracellular Matrix in Hypertensive Heart Disease & Transition to Heart Failure

FWCI

0.92

Citation Percentile

0.7%

Citation Trend

2022

2024

2025

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0262479&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0262479&type=printable

journalhttps://doi.org/10.1371/journal.pone.0262479

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35015787

repositoryhttps://doaj.org/article/b2818ec744064abeb8f2504d4b93476d

Fields of Study

Cardiac Fibrosis and RemodelingCardiovascular Function and Risk FactorsCardiomyopathy and Myosin Studies03 medical and health sciences0302 clinical medicine

MeSH Terms

AgedCells, CulturedFemaleFibroblastsFibrosisHeart FailureHeart VentriclesHumansHypertensionMaleMiddle AgedMyocardiumPrognosisBiomarkersCase-Control StudiesCell Proliferation

Keywords

MedicineHeart failure with preserved ejection fractionCardiologyHeart failureInternal medicineEjection fractionDiastoleCardiac function curveBlood pressureMaleScienceHeart VentriclesMyocardiumQRFibroblastsMiddle AgedPrognosisFibrosisCase-Control StudiesHypertensionHumansFemaleBiomarkersCells, CulturedResearch ArticleAgedCell Proliferation

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being